Literature DB >> 30381386

British man with CJD gets experimental treatment in world first.

Clare Dyer1.   

Abstract

Entities:  

Year:  2018        PMID： 30381386     DOI： 10.1136/bmj.k4608

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  4 in total

1.  Multimodal small-molecule screening for human prion protein binders.

Authors:  Andrew G Reidenbach; Michael F Mesleh; Dominick Casalena; Sonia M Vallabh; Jayme L Dahlin; Alison J Leed; Alix I Chan; Dmitry L Usanov; Jenna B Yehl; Christopher T Lemke; Arthur J Campbell; Rishi N Shah; Om K Shrestha; Joshua R Sacher; Victor L Rangel; Jamie A Moroco; Murugappan Sathappa; Maria Cristina Nonato; Kong T Nguyen; S Kirk Wright; David R Liu; Florence F Wagner; Virendar K Kaushik; Douglas S Auld; Stuart L Schreiber; Eric Vallabh Minikel
Journal:  J Biol Chem       Date:  2020-07-28       Impact factor: 5.157

2.  Treatment of microglia with Anti-PrP monoclonal antibodies induces neuronal apoptosis in vitro.

Authors:  Utpal Kumar Adhikari; Elif Sakiz; Umma Habiba; Meena Mikhael; Matteo Senesi; Monique Antoinette David; Gilles J Guillemin; Lezanne Ooi; Tim Karl; Steven Collins; Mourad Tayebi
Journal:  Heliyon       Date:  2021-12-21

3.  Ligands binding to the prion protein induce its proteolytic release with therapeutic potential in neurodegenerative proteinopathies.

Authors:  Luise Linsenmeier; Behnam Mohammadi; Mohsin Shafiq; Karl Frontzek; Julia Bär; Amulya N Shrivastava; Markus Damme; Feizhi Song; Alexander Schwarz; Stefano Da Vela; Tania Massignan; Sebastian Jung; Angela Correia; Matthias Schmitz; Berta Puig; Simone Hornemann; Inga Zerr; Jörg Tatzelt; Emiliano Biasini; Paul Saftig; Michaela Schweizer; Dmitri Svergun; Ladan Amin; Federica Mazzola; Luca Varani; Simrika Thapa; Sabine Gilch; Hermann Schätzl; David A Harris; Antoine Triller; Marina Mikhaylova; Adriano Aguzzi; Hermann C Altmeppen; Markus Glatzel
Journal:  Sci Adv       Date:  2021-11-24       Impact factor: 14.136

4.  Protective anti-prion antibodies in human immunoglobulin repertoires.

Authors:  Karl Frontzek; Marc Emmenegger; Assunta Senatore; Andra Chincisan; Marco Losa; Regina Reimann; Geraldine Horny; Jingjing Guo; Sylvie Fels; Silvia Sorce; Caihong Zhu; Nathalie George; Stefan Ewert; Thomas Pietzonka; Simone Hornemann; Adriano Aguzzi
Journal:  EMBO Mol Med       Date:  2020-08-10       Impact factor: 12.137
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.